{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:01:08Z","timestamp":1790870468783,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T00:00:00Z","timestamp":1282867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s12149-010-0405-7","type":"journal-article","created":{"date-parts":[[2010,8,26]],"date-time":"2010-08-26T03:10:26Z","timestamp":1282792226000},"page":"639-647","source":"Crossref","is-referenced-by-count":2,"title":["Technetium-99m depreotide imaging by single photon emission tomography\/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate"],"prefix":"10.1007","volume":"24","author":[{"given":"Dimitris J.","family":"Apostolopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos I.","family":"Papandrianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argiris","family":"Symeonidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tryfon","family":"Spyridonidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotiria","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Zampakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Savvopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlos J.","family":"Vassilakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Matsouka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,27]]},"reference":[{"issue":"Suppl 1","key":"405_CR1","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1007\/s00259-003-1159-4","volume":"30","author":"SJ Vinnicombe","year":"2003","unstructured":"Vinnicombe SJ, Reznek RH. Computerised tomography in the staging of Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma. Eur J Nucl Med Mol Imaging. 2003;30(Suppl 1):S42\u201355.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"405_CR2","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/s00259-003-1164-7","volume":"30","author":"E Even-Sapir","year":"2003","unstructured":"Even-Sapir E, Israel O. Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma. Eur J Nucl Med Mol Imaging. 2003;30(Suppl 1):S65\u201381.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"405_CR3","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00259-005-1788-x","volume":"32","author":"B Palumbo","year":"2005","unstructured":"Palumbo B, Sivolella S, Palumbo I, Liberati AM, Palumbo R. 67\u00a0Ga-SPECT\/CT with a hybrid system in the clinical management of lymphoma. Eur J Nucl Med Mol Imaging. 2005;32:1011\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"405_CR4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3816\/CLM.2000.n.007","volume":"1","author":"L Kostakoglu","year":"2000","unstructured":"Kostakoglu L, Goldsmith SJ. Positron emission tomography in lymphoma: comparison with computed tomography and gallium-67 single photon emission computed tomography. Clin Lymphoma. 2000;1:67\u201374.","journal-title":"Clin Lymphoma"},{"issue":"Suppl 1","key":"405_CR5","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1007\/s00259-003-1169-2","volume":"30","author":"SF Barrington","year":"2003","unstructured":"Barrington SF, O\u2019Doherty MJ. Limitations of PET for imaging lymphoma. Eur J Nucl Med Mol Imaging. 2003;30(Suppl 1):S117\u201327.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"405_CR6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1053\/j.semnuclmed.2005.03.001","volume":"35","author":"D Ferone","year":"2005","unstructured":"Ferone D, Semino C, Boschetti M, Cascini GL, Minuto F, Lastoria S. Initial staging of lymphoma with octreotide and other receptor imaging agents. Semin Nucl Med. 2005;35:176\u201385.","journal-title":"Semin Nucl Med"},{"key":"405_CR7","first-page":"916","volume":"37","author":"N Leners","year":"1996","unstructured":"Leners N, Jamar F, Fiasse R, Ferrant A, Pauwels S. Indium- 111-Pentetreotide Uptake in Endocrine Tumors and Lymphoma. J Nucl Med. 1996;37:916\u201322.","journal-title":"J Nucl Med"},{"key":"405_CR8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/BF00800590","volume":"22","author":"L Sarda","year":"1995","unstructured":"Sarda L, Duet M, Zini JM, Berolatti B, Benelhadj S, Tobelem G, et al. Indium-111 pentetreotide scintigraphy in malignant lymphomas. Eur J Nucl Med. 1995;22:1105\u20139.","journal-title":"Eur J Nucl Med"},{"key":"405_CR9","first-page":"13","volume":"36","author":"RW Lipp","year":"1995","unstructured":"Lipp RW, Silly H, Ranner G, Dobnig H, Passath A, Leb G, et al. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy. J Nucl Med. 1995;36:13\u20138.","journal-title":"J Nucl Med"},{"key":"405_CR10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/10428199709109164","volume":"26","author":"V Ivancevi\u0107","year":"1997","unstructured":"Ivancevi\u0107 V, W\u00f6rmann B, Nauck C, Sandrock D, Munz DL, Hiddemann W, et al. Somatostatin receptor scintigraphy in the staging of lymphomas. Leuk Lymphoma. 1997;26:107\u201314.","journal-title":"Leuk Lymphoma"},{"key":"405_CR11","first-page":"222","volume":"42","author":"PJ Lugtenburg","year":"2001","unstructured":"Lugtenburg PJ, L\u00f6wenberg B, Valkema R, Oei HY, Lamberts SW, Eijkemans MJ, et al. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin\u2019s lymphomas. J Nucl Med. 2001;42:222\u20139.","journal-title":"J Nucl Med"},{"key":"405_CR12","first-page":"56","volume":"27","author":"R Bares","year":"1993","unstructured":"Bares R, Galonska P, Dempke W, Handt S, B\u00fcll U, Osieka R. Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography. Horm Metab Res Suppl. 1993;27:56\u20138.","journal-title":"Horm Metab Res Suppl"},{"key":"405_CR13","first-page":"1850","volume":"58","author":"I Virgolini","year":"1998","unstructured":"Virgolini I, Leimer M, Handmaker H, Lastoria S, Bischof C, Muto P, et al. Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829. Cancer Res. 1998;58:1850\u20139.","journal-title":"Cancer Res"},{"key":"405_CR14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/jnci\/91.8.716","volume":"91","author":"M Raderer","year":"1999","unstructured":"Raderer M, Valencak J, Pfeffel F, Drach J, Pangerl T, Kurtaran A, et al. Somatostatin receptor expression in primary gastric versus nongastric extranodal B-cell lymphoma of mucosa-associated lymphoid tissue type. J Natl Cancer Inst. 1999;91:716\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"405_CR15","first-page":"8","volume":"45","author":"VASH Dalm","year":"2004","unstructured":"Dalm VASH, Hofland LJ, Mooy CM, Waaijers MA, van Koetsveld PM, Langerak AW, et al. Somatostatin receptors in malignant lymphomas: targets for radiotherapy? J Nucl Med. 2004;45:8\u201316.","journal-title":"J Nucl Med"},{"key":"405_CR16","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s00259-003-1449-x","volume":"31","author":"W Cholewinski","year":"2004","unstructured":"Cholewinski W, Kowalczyk JR, Stefaniak B, Stefaniak J, Poniatowicz-Frasunek E, Tarkowska A. Diagnosis and staging of children\u2019s lymphoma using the technetium-labelled somatostatin analogue, 99mTc-depreotide. Eur J Nucl Med Mol Imaging. 2004;31:820\u20134.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"405_CR17","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/01.mnm.0000126628.01919.f9","volume":"25","author":"DL Bushnell","year":"2004","unstructured":"Bushnell DL, Menda Y, Madsen MT, Link BK, Kahn D, Truhlar SM, et al. 99mTc-depreotide tumour uptake in patients with non-Hodgkin\u2019s lymphoma. Nucl Med Commun. 2004;25:839\u201343.","journal-title":"Nucl Med Commun"},{"key":"405_CR18","first-page":"503","volume":"28","author":"JL Montilla-Soler","year":"2003","unstructured":"Montilla-Soler JL, Rexroad JT, Bridwell RS. Tc-99m depreotide scintigraphy of low-grade non-Hodgkin\u2019s lymphoma. Clin Nucl Med. 2003;28:503\u20135.","journal-title":"Clin Nucl Med"},{"key":"405_CR19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/01.rlu.0000082679.05827.33","volume":"28","author":"R Danielsson","year":"2003","unstructured":"Danielsson R, B\u00e5\u00e5th M, K\u00f6lbeck K-G, Klominek J, Svensson L. Accumulation of Tc-99m depreotide (NeoSpect) in axillary sweat glands. Clin Nucl Med. 2003;28:789\u201390.","journal-title":"Clin Nucl Med"},{"key":"405_CR20","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1046\/j.1365-2141.2001.02583.x","volume":"112","author":"PJ Lugtenburg","year":"2001","unstructured":"Lugtenburg PJ, Krenning EP, Valkema R, Oei HY, Lamberts SW, Eijkemans MJ, et al. Somatostatin receptor scintigraphy useful in stage I-II Hodgkin\u2019s disease: more extended disease identified. Br J Haematol. 2001;112:936\u201344.","journal-title":"Br J Haematol"},{"issue":"Suppl 2","key":"405_CR21","first-page":"63","volume":"31","author":"S Lastoria","year":"1999","unstructured":"Lastoria S, Palmieri G, Muto P, Lombardi G. Functional imaging of thymic disorders. Ann Med. 1999;31(Suppl 2):63\u20139.","journal-title":"Ann Med"},{"key":"405_CR22","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ijc.2910500613","volume":"50","author":"JC Reubi","year":"1992","unstructured":"Reubi JC, Waser B, van Hagen M, Lamberts SWJ. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas. Int J Cancer. 1992;50:895\u2013900.","journal-title":"Int J Cancer"},{"key":"405_CR23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cncr.21967","volume":"107","author":"M Karam","year":"2006","unstructured":"Karam M, Novak L, Cyriac J, Ali A, Nazeer T, Nugent F. Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas. Cancer. 2006;107:175\u201383.","journal-title":"Cancer"},{"key":"405_CR24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2967\/jnumed.109.067892","volume":"51","author":"M Weiler-Sagie","year":"2010","unstructured":"Weiler-Sagie M, Bushelev O, Epelbaum R, Dann EJ, Haim N, Avivi I, et al. (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. J Nucl Med. 2010;51:25\u201330.","journal-title":"J Nucl Med"},{"key":"405_CR25","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1054\/bjoc.2001.2070","volume":"85","author":"M Raderer","year":"2001","unstructured":"Raderer M, Traub T, Formanek M, Virgolini I, Osterreicher C, Fiebiger W, et al. Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type. Br J Cancer. 2001;85:1462\u20136.","journal-title":"Br J Cancer"},{"issue":"Suppl 1","key":"405_CR26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10428190802311425","volume":"49","author":"O Landgren","year":"2008","unstructured":"Landgren O, Tilly H. Epidemiology, pathology and treatment of non-follicular indolent lymphomas. Leuk Lymphoma. 2008;49(Suppl 1):35\u201342.","journal-title":"Leuk Lymphoma"},{"key":"405_CR27","doi-asserted-by":"crossref","unstructured":"Mazloom A, Medeiros LJ, McLaughlin PW, Reed V, Cabanillas FF, Fayad LE, et al. Marginal zone lymphomas: factors that affect the final outcome. Cancer 2010 [Epub ahead of print].","DOI":"10.1002\/cncr.25325"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-010-0405-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-010-0405-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-010-0405-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T04:41:17Z","timestamp":1559450477000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-010-0405-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,27]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["405"],"URL":"https:\/\/doi.org\/10.1007\/s12149-010-0405-7","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,27]]}}}